Pharmaceutical Industry Articles & Reports

Learn frameworks for GxP-safe AI. Covers RAG, audit trails, and data isolation to ensure 21 CFR Part 11 and Annex 11 compliance in pharma.

Review 10 years of FDA 483 patterns and EMA reports. Learn the four core inspection question clusters and the specific evidence required for compliance.

Learn about the impact of AI agents on B2B productivity in 2026. This analysis details enterprise adoption trends, case studies, and Anthropic's technical visio

Explore Project Orbis, the FDA's global oncology review framework. Analyze approval timelines, partner agencies, and challenges in expanding beyond cancer.

Explore Project Orbis, the FDA framework for simultaneous oncology drug review. Understand how international partners coordinate to reduce approval delays.

Examine Project Orbis data on FDA oncology approvals. Analysis shows concurrent review reduced submission gaps to 33 days and accelerated access by 2.6 months.

Analyze how FDA inspection delays and regulatory bottlenecks impact patient safety and drug supply. Learn how AI tools are addressing these critical backlogs.

Learn how FDA QMSR impacts 21 CFR 820. Internal audit and management review records are no longer confidential and subject to inspection under the new rule.

Analyze 2026 strategies for AI-assisted 510(k) submissions. Covers FDA guidance, generative AI tools, and mandatory human oversight protocols.

Analyze the 2026 surge in FDA warning letters for contract manufacturers. Review data integrity risks, regulatory updates, and supply chain oversight strategies

Analyze the FDA QMSR final rule, ISO 13485 alignment, and the new CP 7382.850 inspection playbook. Learn key compliance steps for device manufacturers.

Analyze FDA Project Elsa, a generative AI system that prioritizes facility inspections by detecting risk patterns in adverse events and regulatory data.

Analyze the FDA Quality Management System Regulation (QMSR) effective Feb 2, 2026. Learn how ISO 13485:2016 incorporation impacts medical device compliance.

Analyze the integration of AI with Lean Six Sigma in MedTech. Reviews DMAIC enhancements, regulatory compliance, and predictive quality management systems.

Analyze FDA QMSR requirements for DHF remediation. Learn how to transition legacy Design History Files to the ISO 13485 Medical Device File framework.

Analyze corporate AI training models: Build, Buy, and Hybrid. Review 2026 costs, upskilling strategies, and implementation data for L&D decision-makers.

Guide to drafting a corporate AI policy. Covers governance frameworks, risk mitigation, and compliance with regulations like the EU AI Act and ISO 42001.

Analyze ChatGPT Deep Research features and RAG technology. Understand agentic workflows, automated literature reviews, and accuracy limitations.

Explore the clinical trial regulatory pathway involving FDA, IRBs, and global agencies. Understand approval timelines, compliance steps, and review delays.

Analyze the readiness decay curve and why mock inspections fail. Learn how skill atrophy, CAPA drift, and cognitive biases erode regulatory compliance.

Examine AI hallucinations in business. Learn why LLMs fabricate data, understand the risks, and review technical prevention strategies like RAG.

Learn prompt engineering strategies for business teams. Covers zero-shot, few-shot, and chain-of-thought techniques to optimize AI workflows without coding.

Analyze AI in clinical operations: a guide to workflow automation, scribes, and predictive scheduling. Review use cases, tools, and implementation steps.

Learn to deploy Google Gemini Enterprise. This guide covers agentic AI architecture, data grounding, security protocols, and integration strategies.